Company Filing History:
Years Active: 2006
Title: Francois-Xavier Mahon: Innovator in Leukemia Treatment
Introduction
Francois-Xavier Mahon is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of leukemia treatment, particularly focusing on Philadelphia-positive leukemia. Although he currently holds no granted patents, his work in research and development has been influential.
Latest Patent Applications
Francois-Xavier Mahon has submitted several patent applications, including:
1. **Method of Optimizing the Treatment of Philadelphia-positive Leukemia with Abl Tyrosine Kinase Inhibitors** - This invention provides a method for treating Philadelphia positive (Ph+) leukemia, such as Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) or chronic myeloid leukemia (CML), in a human patient population.
2. **Organic Compounds** - This application relates to isolated polypeptides that comprise a mutated functional Abl kinase domain, which is resistant to inhibition of its tyrosine kinase activity. The invention also covers the use of these polypeptides to screen for compounds that inhibit their tyrosine kinase activity.
Conclusion
Francois-Xavier Mahon is a dedicated inventor whose research focuses on improving treatments for leukemia. His innovative approaches in the field highlight the importance of ongoing research in medical science.